Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The principal results of the International Immune Tolerance Study: a randomized dose comparison
2011
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets
2007
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
LAD-1/variant syndrome is caused by mutations in FERMT3
2008
The primacy of affinity over clustering in regulation of adhesiveness of the integrin αLβ2
2004
Management of Stroke in Infants and Children
2008
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study
2006
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
2001
Rational Design of Intercellular Adhesion Molecule-1 (ICAM-1) Variants for Antagonizing Integrin Lymphocyte Function-associated Antigen-1-dependent Adhesion
2005 StandoutNobel
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
2006
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Mechanisms of Thrombus Formation
2008 Standout
Visceral obesity and metabolic syndrome
2000
Environmental sensing through focal adhesions
2008 Standout
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors
2009
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
The risk associated with indwelling catheters in children with haemophilia
2007
Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis
2007
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
2010
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
2004
The role of autophagy in neurodegenerative disease
2013 Standout
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
2009 Standout
Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation
2009
Severe Congenital Neutropenia
2006
LAD-III, a novel group of leukocyte integrin activation deficiencies
2003
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
2016
Focal adhesion kinase: in command and control of cell motility
2005 Standout
International workshop on immune tolerance induction: consensus recommendations1
2007
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Lipid-based amphotericin B: a review of the last 10 years of use
2001
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence‐based approaches
2010
Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo
2012 Standout
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
2009
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Home‐based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia
2001
Recommendations for assessment, monitoring and follow‐up of patients with haemophilia
2011
Psycho‐social determinants of quality of life in children and adolescents with haemophilia—a cross‐cultural approach
2008
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience
2007
Emergency Department Care for Patients with Hemophilia and Von Willebrand Disease
2008
Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia
2001
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Hermansky–Pudlak syndrome: a disease of protein trafficking and organelle function
2006
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders
2007
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
2008
Antithrombotic Therapy for VTE Disease
2012 Standout
Neutrophils and immunity: challenges and opportunities
2006 Standout
Home management of haemophilia
2004
Heterogeneous expression pattern of pro‐ and anti‐apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony‐stimulating factor
2005
Neutrophil extracellular traps in immunity and disease
2017 Standout
Immune tolerance induction in haemophilia: evidence and the way forward
2011
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Central venous access devices in haemophilia
2004
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Is visceral obesity the cause of the metabolic syndrome?
2006
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
1999
Sickle-cell disease
2010 Standout
Long term survivors of childhood leukemia
2000
Neutrophils, from Marrow to Microbes
2010 Standout
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
2002
Antithrombotic Therapy in Neonates and Children
2008
Antithrombotic Therapy in Neonates and Children
2012
Clinical implications of ELA2‐, HAX1‐, and G‐CSF‐receptor (CSF3R) mutations in severe congenital neutropenia
2008
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
2001
Considerations in the evaluation of haemophilia patients for short‐term prophylactic therapy: a paediatric and adult case study
2005
Neutrophils in cancer: neutral no more
2016 Standout
Getting to the site of inflammation: the leukocyte adhesion cascade updated
2007 Standout
Haemophilias A and B
2003
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Intracranial hemorrhage in children with congenital factor deficiencies
2011
Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III
2007
Surgery and inhibitor development in hemophilia A: a systematic review
2011
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008)
2010
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high‐titre inhibitors
2007
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
Management options for dental extraction in hemophiliacs: A study of 55 extractions (2000–2002)
2005
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Integrins in immunity
2008
Risk Factors for Arterial Ischemic Stroke in Children
2000
The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
2002
Transcranial Doppler Screening Among Children and Adolescents With Sickle Cell Anemia
2016
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
2008
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Contributions to Neutropenia from PFAAP5 (N4BP2L2), a Novel Protein Mediating Transcriptional Repressor Cooperation between Gfi1 and Neutrophil Elastase
2009
Integrin activation
2004
Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro
2010
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
TLR2 Transmodulates Monocyte Adhesion and Transmigration via Rac1- and PI3K-Mediated Inside-Out Signaling in Response toPorphyromonas gingivalisFimbriae
2006
Neutrophil elastase in cyclic and severe congenital neutropenia
2006
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
2002
ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor
2009
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Guidelines for the management of hemophilia
2012 Standout
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Frequency, Predictors, and Neurologic Outcomes of Vaso-occlusive Strokes Associated With Cardiac Surgery in Children
2008
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of Ri Liesner being referenced
Central venous access devices in children with congenital coagulation disorders: complications and long‐term outcome
2000
Guideline on the management of haemophilia in the fetus and neonate*
2011
A novel form of integrin dysfunction involving β1, β2, and β3 integrins
2003
Long‐term follow‐up of granulocyte colony‐stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy
2003
Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia
2004
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Long‐term consequences of intracranial haemorrhage in children with haemophilia
2008
Treatment related factors and inhibitor development in children with severe haemophilia A
2010
Use of central venous catheters in children with severe congenital coagulopathy
1995
Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients
2008
Normal Lytic Granule Secretion by Cytotoxic T Lymphocytes Deficient in BLOC‐1, ‐2 and ‐3 and Myosins Va, VIIa and XV
2005
Complications experienced with central venous catheters in children with congenital bleeding disorders
1997
Inherited prothrombotic states and ischaemic stroke in childhood
1998
Intranasal desmopressin (OctimTM): a safe and efficacious treatment option for children with bleeding disorders
2007
Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
2009
Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood.
1994
The impact of prophylactic treatment on children with severe haemophilia
1996
Stem cell transplantation for children with Glanzmann thrombasthenia
2008
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors
2002
Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A
2007
Acute neonatal arterial occlusion: is thrombolysis safe and effective?
2008
Performance of the platelet function analyser PFA-100?? in testing abnormalities of primary haemostasis
1999
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children
2004
Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease
2001
The use of recombinant factor VIIa in children with inherited platelet function disorders
2003
Sudden Death in Sickle Cell Disease
1993
A novel form of integrin dysfunction involving β1, β2, and β3 integrins
2003
Non-accidental injury and the haematologist
2004
Mutations in ELA2 encoding for neutrophil elastase are a frequent finding in sporadic but not familial severe congenital neutropenia.
2000
Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia
2002